Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Gary Jay Brenner, M.D.,Ph.D.

Co-Author

This page shows the publications co-authored by Gary Brenner and Sherif Ahmed.
Connection Strength

3.746
  1. Correction to: Schwannoma gene therapy by adeno-associated virus delivery of the pore-forming protein Gasdermin-D. Cancer Gene Ther. 2020 04; 27(3-4):265.
    View in: PubMed
    Score: 0.904
  2. Gene therapy with apoptosis-associated speck-like protein, a newly described schwannoma tumor suppressor, inhibits schwannoma growth in vivo. Neuro Oncol. 2019 07 11; 21(7):854-866.
    View in: PubMed
    Score: 0.860
  3. Developing myelin specific promoters for schwannoma gene therapy. J Neurosci Methods. 2019 07 15; 323:77-81.
    View in: PubMed
    Score: 0.852
  4. Schwannoma gene therapy by adeno-associated virus delivery of the pore-forming protein Gasdermin-D. Cancer Gene Ther. 2019 09; 26(9-10):259-267.
    View in: PubMed
    Score: 0.831
  5. Transcriptomic signature of painful human neurofibromatosis type 2 schwannomas. Ann Clin Transl Neurol. 2021 07; 8(7):1508-1514.
    View in: PubMed
    Score: 0.245
  6. NLRP3 inflammasome activation in human vestibular schwannoma: Implications for tumor-induced hearing loss. Hear Res. 2019 09 15; 381:107770.
    View in: PubMed
    Score: 0.054
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.